Misplaced Pages

Guanidine

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 10:45, 9 August 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 10:45, 9 August 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Guanidine
Skeletal formula of guanidine
Ball-and-stick model of guanidine
Names
IUPAC name Guanidine
Identifiers
CAS Number
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.003.656 Edit this at Wikidata
PubChem CID
UNII
CompTox Dashboard (EPA)
InChI
  • InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)Key: ZRALSGWEFCBTJO-UHFFFAOYSA-N
  • InChI=1/CH5N3/c2-1(3)4/h(H5,2,3,4)Key: ZRALSGWEFCBTJO-UHFFFAOYAY
SMILES
  • C(=N)(N)N
Properties
Chemical formula CH5N3
Molar mass 59.07 g/mol
Melting point 50 °C
Acidity (pKa) 13.6 (guanidinium cation)
Related compounds
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). checkverify (what is  ?) Infobox references
Chemical compound

Guanidine is a crystalline compound of strong alkalinity formed by the oxidation of guanine. It is used in the manufacture of plastics and explosives. It is found in urine as a normal product of protein metabolism. The molecule was first synthesized in 1861 by the oxidative degradation of an aromatic natural product, guanine, isolated from Peruvian guano. Despite the simplicity of the molecule, the crystal structure was first described 148 years later.

Bottle of guanidine for use in the laboratory.

Guanidinium cation

Guanidine is protonated in physiological conditions. This conjugate acid is called the guanidinium cation, . The guanidinium cation has a charge of +1. It is a highly stable cation in aqueous solution due to the efficient resonance stabilization of the charge and efficient solvation by water molecules. As a result, its pKa is 13.6 meaning that guanidine is a very strong base in water.

Notable guanidinium salts include guanidinium chloride (GndCl), which has chaotropic properties and is used to denature proteins. Empirically, guanidine hydrochloride is known to denature proteins with a linear relationship between concentration and free energy of unfolding. Another such salt is guanidinium thiocyanate.

Guanidine derivatives

The general structure of a guanidine

Guanidines are a group of organic compounds sharing a common functional group with the general structure (RRN)(RRN)C=N-R. The central bond within this group is that of an imine, and the group is related structurally to amidines and ureas. Examples of guanidines are arginine, triazabicyclodecene and saxitoxin. Another derivative is guanidinium hydroxide, the active ingredient in some non-lye hair relaxers. Guanidinium salts are well known for their denaturing action on proteins; guanidinium chloride is one of the most effective denaturants. In 6 M aqueous GndHCl almost all proteins lose their ordered "secondary structure" (that results from intramolecular noncovalent interactions) and become "randomly coiled"; that is, their secondary structure interactions are disrupted by the dissolved guanidinium, leaving only the primary covalent structure of their polyamide backbones.

See also

References

  1. ^ Perrin, D.D., Dissociation Constants of Organic Bases in Aqueous Solution, Butterworths, London, 1965; Supplement, 1972.
  2. A. Strecker, Liebigs Ann. Chem. 1861, 118, 151.
  3. T. Yamada, X. Liu, U. Englert, H. Yamane, R. Dronskowski, Chem. Eur. J. 2009, 15, 5651.
Sympatholytic (and closely related) antihypertensives (C02)
Sympatholytics
(antagonize α-adrenergic
vasoconstriction)
Central
α2-Adrenergic receptor agonists
Adrenergic release inhibitors
Imidazoline receptor agonists
Ganglion-blocking/nicotinic antagonists
Peripheral
Indirect
Monoamine oxidase inhibitors
VMAT inhibitors
Tyrosine hydroxylase inhibitors
Direct
α1-Adrenergic receptor blockers
Non-selective α-adrenergic receptor blockers
Other antagonists
Serotonin receptor antagonists
Endothelin receptor antagonists (for PHTooltip Pulmonary hypertension)
Category: